OS Therapies Inc (OSTX) stock
OSTXNYSEPharmaceutical PreparationsFiscal year ends December 31
$0.92+0.18 (+23.51%)
Close on Nov 18, 2026Market cap $42.43MP/E –Yield –
OS Therapies free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
OS Therapies's free cash flow for the twelve months ending Dec 31, 2025 was -$14.70M. For fiscal 2025 it was -$14.70M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$14.70M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -$3.73M | – |
| Q3 FY2025 | Sep 30, 2025 | -$4.71M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.68M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.59M | – |
| Q3 FY2023 | Sep 30, 2023 | -$876.57K | – |
See a number that looks wrong?